Abstract: Systems and methods are provided for look-alike sound-alike medication error messaging. Prescription data relating to a prescription is parsed to identify a submitted drug product and a submitted daily dosage. An absolute dose screening process may be executed to determine whether the submitted daily dosage meets absolute dosing criteria for the submitted drug product. A typical dose screening process may be executed to determine whether the submitted daily dosage meets statistically derived typical dosing criteria for the submitted drug product and any look-alike sound-alike alternative drug products. If it is determined that the prescription should be rejected based on typical dosing criteria or absolute dosing criteria, a reject message may be built for presentation to the pharmacist.

Abstract: Systems and methods are provided for look-alike sound-alike medication error messaging. Prescription data relating to a prescription is parsed to identify a submitted drug product and a submitted daily dosage. An absolute dose screening process may be executed to determine whether the submitted daily dosage meets absolute dosing criteria for the submitted drug product. A typical dose screening process may be executed to determine whether the submitted daily dosage meets statistically derived typical dosing criteria for the submitted drug product and any look-alike sound-alike alternative drug products. In addition, one or more likelihood indicators may be assigned to the submitted drug product in relation to associated look-alike sound-alike drug pairs. If it is determined that the prescription should be rejected based on typical dosing criteria, absolute dosing criteria, or the likelihood indicator(s), a reject message may be built for presentation to the pharmacist.

Abstract: A folding leaf gate comprising a post hung section hingedly attachable to a gate post and at least one leaf hung section hingedly connected in series with the post hung section by means of one or more section hinges, wherein the folding leaf gate additionally includes a rotating device associated with the or each leaf hung section and sharing a common axis of rotation with the or each section hinge and secured in a static relationship to a leaf hung section whereby rotation of the or each rotating device causes rotation of a leaf hung section about the or each section hinge, and one or more translating devices engaging the or each rotating devices, the one or more translating device being configured, when in use, to translate rotational motion of the post hung section about a gate post to rotation of the one or more rotating devices whereby simultaneously to open a gateway closed by the folding leaf gate and fold the folding leaf gate in two or more.

Abstract: A configurable motorcycle exhaust assembly, including an elongated hollow body; an inlet end cap fixedly connected to an inlet end of the elongated hollow body; an exhaust end mount fixedly connected to an exit end of the elongated hollow body; and an exhaust end cap removably attached to the exhaust end mount.

Abstract: A configurable motorcycle exhaust assembly, including an elongated hollow body; an inlet end cap fixedly connected to an inlet end of the elongated hollow body; an exhaust end mount fixedly connected to an exit end of the elongated hollow body; and an exhaust end cap removably attached to the exhaust end mount.

Abstract: The present invention is a chemical compound of formula (I) or a pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4, A1, A2 m and n are as described in the specification.

Abstract: A method of communications employs a communications protocols defining respective responses to predetermined events. The protocol is separated into a first group of behaviours defining responses to corresponding first, relatively frequently occurring, events, and a second group of behaviours defining responses to corresponding first, relatively frequently occurring, events, and a second group of behaviours defining responses to corresponding second, relatively infrequently occurring events. The first group is stored at a user communications terminal. At least the second group is stored at a store remote from the user terminal, and interconnected therewith via a communications channel. Communication is established from the user terminal using first events. On detecting an event other than one of said the first events at the user terminal, event holding data is signaled from the store to the user terminal; and communication is established from the user terminal using the event-handling data.

Abstract: The present invention is a chemical compound of formula (I) 1

Abstract: Systems and methods are provided for medication error messaging. Prescription data is parsed to identify a submitted drug product and a submitted daily dosage. An absolute dose screening process may be executed to determine whether the submitted daily dosage meets absolute dosing criteria for the submitted drug product. A typical dose screening process may be executed to determine whether the submitted daily dosage meets statistically derived typical dosing criteria for the submitted drug product. If it is determined that the prescription should be rejected based on typical dosing criteria or absolute dosing criteria, a reject message may be built for presentation to the pharmacist.

Abstract: Systems and methods are provided for look-alike sound-alike medication error messaging. Prescription data relating to a prescription is parsed to identify a submitted drug product and a submitted daily dosage. An absolute dose screening process may be executed to determine whether the submitted daily dosage meets absolute dosing criteria for the submitted drug product. A typical dose screening process may be executed to determine whether the submitted daily dosage meets statistically derived typical dosing criteria for the submitted drug product and any look-alike sound-alike alternative drug products. In addition, one or more likelihood indicators may be assigned to the submitted drug product in relation to associated look-alike sound-alike drug pairs. If it is determined that the prescription should be rejected based on typical dosing criteria, absolute dosing criteria, or the likelihood indicator(s), a reject message may be built for presentation to the pharmacist.

Abstract: Systems and methods are provided for look-alike sound-alike medication error messaging. Prescription data relating to a prescription is parsed to identify a submitted drug product and a submitted daily dosage. An absolute dose screening process may be executed to determine whether the submitted daily dosage meets absolute dosing criteria for the submitted drug product. A typical dose screening process may be executed to determine whether the submitted daily dosage meets statistically derived typical dosing criteria for the submitted drug product and any look-alike sound-alike alternative drug products. In addition, one or more likelihood indicators may be assigned to the submitted drug product in relation to associated look-alike sound-alike drug pairs. If it is determined that the prescription should be rejected based on typical dosing criteria, absolute dosing criteria, or the likelihood indicator(s), a reject message may be built for presentation to the pharmacist.

Abstract: Systems and methods are provided for look-alike sound-alike medication error messaging. Prescription data relating to a prescription is parsed to identify a submitted drug product and a submitted daily dosage. An absolute dose screening process may be executed to determine whether the submitted daily dosage meets absolute dosing criteria for the submitted drug product. A typical dose screening process may be executed to determine whether the submitted daily dosage meets statistically derived typical dosing criteria for the submitted drug product and any look-alike sound-alike alternative drug products. If it is determined that the prescription should be rejected based on typical dosing criteria or absolute dosing criteria, a reject message may be built for presentation to the pharmacist.

Abstract: A Wireless Local Area Network Card (40) with a unit communications port (62) that permits secure transfer of information between the removable communications unit and an introduction device (22) when a proximity based communications port (66) of the introduction device (22) is placed in close proximity to the unit communications port (62). The Card (40) also has a processor (42) connected to the unit communications port (62) and there is a unit connector (52) that allows for complementary releasable engagement of a connector (54) associated with an electronic device (12). The unit connector (52) is connected to the processor (42) and allows communication between the processor (42) and the electronic device (12). A communications interface (48) is connected to the processor for allowing the Card (40) to communicate with at least one other remote Card (40).

Abstract: A chemical compound of formula (I) wherein R1 to R3 are independently selected from hydrogen and alkyl; R4 to R7 are independently selected from hydrogen, halogen, hydroxy, alkyl, aryl, amino, monoalkylamino, dialkylamino, alkoxy, aryloxy, alkylthio, arylthio, arylsulfoxyl, arylsulfonyl, alkylsulfoxyl, alkylsulfonyl, nitro, cyano, carboxaldehyde, alkylcarbonyl, arylcarbonyl, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonylamino, aminocarbonyloxy, monoalkylaminocarbonyloxy, dialkylaminocarbonyloxy, monoalkylaminocarbonylamino and dialkylaminocarbonylamino; and R8 is selected from alkyl and alkoxy, and pharmaceutically acceptable salts and prodrugs thereof, and the use thereof in therapy, particularly for the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea, and particularly for the treatment of obesity.

Abstract: The present invention is a chemical compound of formula (I) 1

Abstract: A method for carrying out sequential reactions, e.g., sequential biochemical reactions, and a rotary thermocycling apparatus especially adapted for conducting such reactions, for example, polymerase chain reactions, are disclosed. The apparatus comprises a plurality of stations, e.g., four stations, for receiving biochemical samples in flat-bottomed containers. Heating means are provided to independently control the temperature of each station, transport means are provided to move the containers from one station to another in a predetermined sequence, and at least one station has a spray unit to spray liquid reagents into a container at that station. The method includes sequentially cycling a sample through predetermined temperature changes and spraying the sample with at least one reagent.

Abstract: A method for carrying out sequential reactions, e.g., sequential biochemical reactions, and a rotary thermocycling apparatus especially adapted for conducting such reactions, for example, polymerase chain reactions, are disclosed. The apparatus comprises a plurality of stations, e.g., four stations, for receiving biochemical samples in flat-bottomed containers. Heating means are provided to independently control the temperature of each station, transport means are provided to move the containers from one station to another in a predetermined sequence, and at least one station has a spray unit to spray liquid reagents into a container at that station. The method includes sequentially cycling a sample through predetermined temperature changes and spraying the sample with at least one reagent.